1+ hour, 36+ min ago   (200+ words) Immune Oncology Research Institute shared on LinkedIn: “What if we could know who is most likely to benefit from immunotherapy – before treatment even begins? In a new Nature Medicine study, Wanxiang Shen and colleagues introduce COMPASS, a pan-cancer AI foundation model…...

11+ hour, 10+ min ago   (80+ words) A New Screening Platform Enabling Researchers to Search for Molecular Glues More Efficiently - Dana-Farber Oncodaily A New Screening Platform Enabling Researchers to Search for Molecular Glues More Efficiently – Dana-Farber Dana-Farber News shared on X: “An article in C&EN describes…...

4+ day, 23+ hour ago   (140+ words) National Cancer Institute (NCI) shared on LinkedIn: While I cannot pretend to predict the future of a technology that is advancing almost weekly, I can see where AI is making a difference and where it is likely headed. AI also…...

5+ day, 19+ hour ago   (116+ words) St. Jude Children’s Research Hospital shared on LinkedIn: The 2026 St. Jude Scientific Report highlights how researchers across the institution are expanding knowledge in pediatric catastrophic diseases while pushing the boundaries of research to improve care for children worldwide. This year’s…...

1+ week, 3+ day ago   (81+ words) Petros Grivas, Professor at University of Washington and Fred Hutch, shared Parminder Singh’s, Medical Oncologist at Mayo Clinic Arizona, post on X, adding: “I agree with Parminder Singh, Present is bright and future will be brighter with amazing talent Bladder…...

1+ week, 4+ day ago   (407+ words) In this editorial, we explore how artificial intelligence is transforming cancer immunotherapy—from improving response prediction and biomarker discovery to advancing CAR-T cell therapies, personalized cancer vaccines, and precision oncology. We also discuss the current barriers to clinical implementation and…...

1+ week, 5+ day ago   (115+ words) Garabet Yeretssian, Director Extramural Research and Partnerships at Biohub, shared a post on LinkedIn: “Last week, spent two days in New York with some of the sharpest minds in immunology, synthetic biology, and AI – all circling the same question: how…...

1+ week, 6+ day ago   (86+ words) Vivek Subbiah: The AI agent Biomni Performs Research Tasks Across Diverse Biomedical Fields Oncodaily Vivek Subbiah: With Further Optimization Biomni Could Be Strong Research Partner for Scientists Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute,…...

1+ week, 6+ day ago   (165+ words) Walid Kamoun, Vice President, Global Head of R/D Oncology at Servier, shared on LinkedIn: ”Summer Reading Series – Less Noise, Better Thinking After reading Aristotle’s Way by Edith Hall, I had an interesting conversation with my dad. He encouraged me…...

2+ week, 1+ day ago   (279+ words) Najat Khan, Chief Commercial Officer at The Janssen Pharmaceutical Companies and board member at Recursion, shared on LinkedIn: “Predicting how tightly a molecule binds to its target is one of the fundamental challenges in drug discovery. Until now, researchers have…...